Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4Head & Neck 2Gastrointestinal 2Other 1Lymphoid 1Gynecologic 1

Conditions

Breast Neoplasms 3Invasive Breast Carcinoma 1Colorectal Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Trastuzumab 692Paclitaxel 678Cyclophosphamide 634Docetaxel 553Capecitabine 467Letrozole 407Carboplatin 392Fulvestrant 377Doxorubicin 330Tamoxifen 288pembrolizumab 270Anastrozole 252Epirubicin 249exemestane 238pertuzumab 226Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Monitoring, Physiologic × Breast × Clear all
NCT03054025 2025-04-29

Smart Phone Application in Increasing Physical Activity in Breast Cancer Survivors

Thomas Jefferson University

Phase NA Terminated
22 enrolled
Breast

Breast Neoplasms

NCT03679559 2023-09-01

Exercise in Improving Health and Quality of Life in Breast Cancer Survivors

Roswell Park Cancer Institute

Phase NA Completed
83 enrolled
Breast

Invasive Breast Carcinoma

NCT02699983 2021-04-13

eHealth Weight Loss Program in African American Breast Cancer Survivors

Rutgers, The State University of New Jersey

Phase NA Completed
35 enrolled 35 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT02677389 2019-11-18

Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin

University of Wisconsin, Madison

Phase NA Completed
100 enrolled
BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡